Hyundai Motor CO August sales fall 14.2 percent on weak domestic demand
The automaker reported a sharp drop in local deliveries while cumulative exports through August declined, even as the CEO pledged an aggressive expansion into new markets and physical AI.

Hyundai Motor CO said Tuesday its total vehicle sales fell 14.2 percent in August from a year earlier, dragged down by a steep contraction in the domestic market. Local deliveries plunged 41.1 percent even as overseas shipments decreased by 8.5 percent.
The company sold 288,574 units globally during the month. For the first eight months of the year, cumulative sales totaled 2.58 million units, down 6 percent compared with the same period in 2025. Domestic volume for this running total fell 15 percent to 399,159 units, while overseas cumulative sales slipped 4.1 percent to 2.18 million units.
Jose Munoz, CEO and president of Hyundai Motor, addressed the company's outlook in a statement released alongside the figures, citing a strategy to offset current headwinds through aggressive expansion. "The fundamentals of Hyundai Motor are stronger than ever," he said. "We will launch more models, provide more powertrain options to our customers, and aggressively enter new segments and markets."
Munoz also outlined a longer-term strategic shift toward advanced mobility solutions, stating the company aims to evolve into a physical artificial intelligence enterprise. "Based on strategic partnerships, we will develop future new technologies, create new opportunities, and transform into a physical AI company that produces and deploys robots and robotaxis," he said.
What this article is based on
Every fact in this article can be checked against the primary documents below.
- Regulatory filing현대자동차 영업(잠정)실적(공정공시)· DART· accessed Sept. 2, 2026
- Other[발언] 호세 무뇨스 현대차 CEO·사장· hyundaimotorgroup.com· accessed Sept. 2, 2026
© New Era Korea Daily. All rights reserved.
More in Companies
- Kumho Engineering wins 145 billion won rail contract in North Gyeongsang
- HLB to absorb HLB Life Science in all-stock merger to unify rivoceranib rights
- L&F raises 30.3 billion won in perpetual convertible bonds for cathode expansion
- Meritz Financial third-quarter revenue jumps 78% as net income slips
- Phionx to raise 13.6 billion won via rights issue and convertible bonds